![](https://investorshub.advfn.com/uicon/434605.png?cb=1493182534)
Tuesday, October 24, 2017 6:43:52 AM
To be sure, it is not the importance/weight of single position within the fund.
CERECOR INC 61.4%
PERNIX THERAPEUTICS HOLD 29.1%
APRICUS BIOSCIENCES INC 11.3%
DYNATRONICS CORP 10.4%
NOVELION THERAPEUTICS INC 9.9%
AYTU BIOSCIENCE INC 9.6%
EYEGATE PHARMACEUTICALS 9.4%
ALIMERA SCIENCES INC 8.5%
OPHTHOTECH CORP 6.7%
DEPOMED INC 6.4%
TANDEM DIABETES CARE INC 5.2%
ADAMAS PHARMACEUTICALS INC 5.1%
ACTINIUM PHARMACEUTICALS INC 5%
INTELLIPHARMACEUTICS 4.7%
Of the mid-cap bio I found BlueBird Bio and Horizon Pharma
Recent IPCI News
- Suspension de la négociation par l'Organisme canadien de réglementation des investissements - IPCI • PR Newswire (Canada) • 03/06/2024 12:55:00 PM
- Canadian Investment Regulatory Organization Trading Halt - IPCI • PR Newswire (Canada) • 03/06/2024 12:51:00 PM
Element79 Gold Corp Appoints Warren Levy to Board of Directors • ELMGF • Aug 28, 2024 9:51 AM
Integrated Ventures Announces Strategic Entry Into Health & Wellness Industry with Focus on GLP-1 Products • INTV • Aug 28, 2024 8:30 AM
ELEMENT79 ANNOUNCES UPLISTING TO OTCQB VENTURE MARKET • ELMGF • Aug 26, 2024 10:03 AM
North Bay Resources Announces Gold Assays up to 2.2 Ounces per Ton, Fran Gold Project, British Columbia • NBRI • Aug 26, 2024 10:00 AM
PickleJar Unveils Latest Venue Managed Services Innovations in Upcoming Webinar • PKLE • Aug 23, 2024 1:11 PM
Element79 Gold Corp Provides Update on Nevada Portfolio • ELMGF • Aug 23, 2024 8:00 AM